Abstract
The article presents the results of clinical trials of the veterinary drug «Mastinol-forte». The effectiveness of the drug in the treatment of the serous-catarrhal form of mastitis was studied in the conditions of a dairy farm. The experiment included cows of a black-and-white Holstein breed weighing 500–550 kg, spontaneously ill with a clinical form of mastitis. Five groups of lactating cows of 2–3 lactation were formed, with a yield of 7–8 thousand l/ year, 18 heads each. The therapeutic efficacy of the drug was evaluated clinically by methods, as well as using a dimastin sample and by counting somatic cells in milk samples. It has been established that the use of the drug «Mastinol-forte» as monotherapy for serouscatarrhal clinical mastitis in cows is well tolerated by animals and gives a positive effect both with intramuscular, subcutaneous, and intracisternal injections. However, the best result was obtained with the combined (subcutaneous and intracisternal) injection of mastinol-forte for 5 days at a dose of 7 ml twice a day.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
